SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tunica Albuginea who wrote (5407)2/11/1998 12:25:00 AM
From: Mkilloran  Read Replies (1) of 23519
 
TA
I expect a pe of 20+ in 99 and with projected earnings of $3.49.........
that's $70+ per share in 99.
The problem is that analyst are too focused on the current qtr's earnings ...when will MCA approval occur...when will FDA certify the new plant.....these are short term issues....look at the longer view.
All these issues will be resolved in the first half of 98...
1999 will have explosive earnings...
This is a great time to buy VVUS...
As soon as the MCA and FDA issues are behind us analyst will revise the current year eps and this stock will take off....however the price will be well above 20 before some analyst will publish their
upgrades.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext